U.S. Industrial REITs Stock News

NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

Is GE HealthCare’s New AI Laptop Ultrasound Push Reshaping Its Imaging Strategy And Moat (GEHC)?

In August 2026, GE HealthCare introduced the LOGIQ e family, LOGIQ e Xi and LOGIQ e Si, compact, AI-enabled laptop ultrasound systems cleared in major markets and designed for fast, confident imaging across multiple clinical settings. The launch highlights GE HealthCare’s push into portable, AI-assisted point-of-care imaging, broadening its ultrasound portfolio and deepening digital integration in clinical workflows. Next, we’ll explore how this AI-powered, portable LOGIQ e launch fits into...
NYSE:NRP
NYSE:NRPOil and Gas

Does Lower Q2 Earnings With Steady Payouts Reveal NRP’s True Capital Allocation Priorities?

Natural Resource Partners L.P. recently reported its second-quarter 2026 results, with revenue of US$48.11 million and net income of US$24.67 million, and the board declared a cash distribution of US$0.75 per common unit for payment on August 25, 2026, to unitholders of record on August 18, 2026. The earnings release showed lower revenue and earnings per unit compared with the same period last year, even as the partnership continued to return cash to unitholders through its quarterly...
NYSE:MMS
NYSE:MMSProfessional Services

How Investors Are Reacting To Maximus (MMS) Q3 Results And Updated 2026 Profit Guidance

In August 2026, Maximus, Inc. reported its fiscal third quarter results, showing quarterly revenue of US$1,278.97 million and net income of US$103.59 million, and updated full-year 2026 guidance to revenue of US$5.2–US$5.35 billion and net income of US$376–US$392 million with diluted EPS of US$6.94–US$7.24. Alongside these results, management reiterated its focus on disciplined acquisitions and share repurchases within a target net debt ratio of 2x–3x, emphasizing deals that expand...
NYSE:TPB
NYSE:TPBTobacco

Turning Point Brands (TPB) Lifts 2026 Guidance, Is The Stock Already Pricey?

Turning Point Brands (TPB) has drawn fresh attention after raising its 2026 earnings guidance tied to Modern Oral products. The update comes alongside recent sales figures and the launch of FRE Labs flavor drops. See our latest analysis for Turning Point Brands. Despite the stronger Modern Oral outlook and the launch of FRE Labs, Turning Point Brands' share price has softened recently, with the stock down 22.62% year to date on a share price basis, while still showing a very large 3 year...
NYSE:UVE
NYSE:UVEInsurance

Universal Insurance Holdings (UVE), What Is Drawing Attention Now?

Universal Insurance Holdings (UVE) has been drawing fresh attention after recent trading, with the stock last closing at $42.69. Investors are weighing this price against the company’s recent returns and current profitability profile. See our latest analysis for Universal Insurance Holdings. Recent trading softness, reflected in the 1-day share price return of 1.20% and 7-day share price return of 1.66%, comes after a stronger run, with a 30-day share price return of 9.71% and year to date...
NYSE:OGS
NYSE:OGSGas Utilities

What ONE Gas (OGS)'s Dividend Hold And New Debt Issue Mean For Shareholders

In early August 2026, ONE Gas, Inc. reported higher second-quarter and first-half net income despite lower sales, affirmed a US$0.68 quarterly dividend payable on August 31, 2026, and completed a US$375 million fixed-rate, callable senior notes offering due 2036 priced at 99.675% of par. Together with amended by-laws that expand the board chair’s committee role, these moves highlight ONE Gas’s focus on reinforcing governance, funding long-lived infrastructure, and sustaining its long-running...
NYSE:DOCS
NYSE:DOCSHealthcare Services

Doximity (DOCS) Earnings Are In Focus As Fair Value Still Sits Higher

Earnings and Guidance Put Doximity Stock in Focus Doximity (DOCS) is in focus after first quarter earnings showed sales of US$156.62 million with lower net income of US$24.32 million, alongside updated revenue guidance for the second quarter and full fiscal year. See our latest analysis for Doximity. Doximity’s share price has climbed 27.31% over the past 90 days and 13.94% over the past month, yet remains down 43.36% year to date, while the 1 year total shareholder return is down 62.81%...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Neurocrine Biosciences (NBIX) Could Be 28% Undervalued On Fresh INGREZZA Data

Neurocrine Biosciences (NBIX) has put INGREZZA back in focus after publishing KINECT-PRO Phase 4 results that link once-daily treatment with sustained improvements in tardive dyskinesia symptoms and patient-reported quality of life in real-world settings. See our latest analysis for Neurocrine Biosciences. The INGREZZA data arrives after a mixed trading patch for Neurocrine Biosciences, with the share price down 9.6% over 30 days but still showing a 9.9% year to date share price return and a...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

East West Bancorp (EWBC) Stock Looks Cheap On Fair Value But Reasonable On Earnings

East West Bancorp stock has returned 168.2% over the past 3 years, yet the latest valuation work suggests a more measured picture, with the Excess Returns intrinsic value estimate pointing to upside while traditional earnings multiples look roughly in line with the market. Over the last 3 years, a 168.2% share price gain places East West Bancorp among the stronger performers, which raises the question of how much of that strength is already reflected in today’s price. Future returns may...
NYSE:NWN
NYSE:NWNGas Utilities

Stronger Q2 Results And Higher 2026 EPS Guidance Might Change The Case For Investing In Northwest Natural Holding (NWN)

Northwest Natural Holding Company recently reported past second-quarter 2026 results showing sales of US$243.55 million and a net income of US$0.6 million, reversing a net loss a year earlier, and modestly higher six-month sales and earnings. The company also indicated that 2026 EPS is now expected to land in the upper half of its US$2.95–US$3.15 guidance range, pointing to stronger operating momentum across its regulated and growth platforms. With management now guiding 2026 EPS toward...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

What Applied Materials (AMAT)'s Record Q3 Results and UC Berkeley AI Push Mean For Shareholders

Applied Materials reported third-quarter 2026 results with sales of US$9.12 billion and net income of US$2.54 billion, alongside raising its fourth-quarter revenue outlook to US$10.25 billion. Beyond the headline numbers, the company continued its multi-year share repurchase program and expanded its EPIC Center research collaboration with UC Berkeley to accelerate AI-focused semiconductor innovation. We’ll now examine how this combination of record quarterly performance and expanded UC...
NYSE:BFH
NYSE:BFHConsumer Finance

What Bread Financial Holdings (BFH)'s July Credit Metrics Update Means For Shareholders

Bread Financial Holdings recently released its July 2026 performance update, outlining shifts in key credit metrics such as net principal loss and delinquency rates compared with a year earlier. This monthly snapshot gives investors a timely view into the health of Bread Financial’s card portfolio and how its risk profile is evolving. We’ll now examine how July’s changes in net principal loss and delinquency rates may alter Bread Financial’s existing investment narrative. Outshine the...
NYSE:DVN
NYSE:DVNOil and Gas

Devon Energy (DVN) Backs Solitude Pipeline JV To Open New Gulf Coast Gas Routes

Devon Energy (NYSE:DVN) has approved moving ahead with the Solitude Pipeline System joint venture with WhiteWater and other partners to move natural gas from the Permian Basin to the Katy, TX hub and Gulf Coast. The multi phase project is designed to expand gas takeaway capacity from the Permian and link Devon volumes to Gulf Coast LNG export and power generation markets. The Solitude Pipeline System is expected to integrate with Devon Energy's existing infrastructure platform and influence...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

Vicor (VICR) Is Up 21.4% After Raising 2026 Revenue Outlook On AI Demand Shift

Earlier in 2026, Vicor raised its full‑year revenue outlook to more than US$600 million and guided to nearly 10% sequential third‑quarter revenue growth, citing strong operating momentum and improving visibility into AI‑related power‑delivery demand. The company also moved ahead with plans for a second fabrication facility designed to roughly double current production capacity, underscoring management’s confidence that AI computing requirements could support significantly higher long‑term...
NYSE:HRL
NYSE:HRLFood

Hormel Foods (HRL) Debuts A New Premium Chili Line

Hormel Foods (NYSE:HRL) has introduced a co-branded premium chili in partnership with Omaha Steaks, combining both companies' branding in a new convenience offering. The company is also rolling out a PLANTERS seasonal fall snack collection, featuring a mix of new and returning limited-time flavors. Both launches target demand for higher-quality convenient meals and seasonal snacking, aiming to deepen customer engagement with Hormel Foods' core brands. Consider exploring other consumer...
NYSE:APAM
NYSE:APAMCapital Markets

Is Artisan Partners' Above‑Earnings Dividend Payout Reframing Its Capital Allocation Story for APAM Investors?

Artisan Partners Asset Management has recently paid a total dividend of US$0.80 per share, following an ex-dividend date of 17 August 2026, extending a dividend record that dates back to 2013. While the dividend offers a high yield appealing to income-focused investors, the payout ratio of 1.03 indicates the company is distributing more than its earnings, raising questions about how reliable this income stream may be over time. Next, we'll examine how concerns around an above-earnings...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb (BMY) Stock May Be 46% Below Fair Value As FDA Approval Lands

Bristol-Myers Squibb stock has delivered a 40.6% 1 year return, while both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to what the business may be worth. The 40.6% gain over the past year suggests sentiment has improved, yet current valuation signals still indicate the market price may be below intrinsic value. Recent FDA accelerated approval for ZENBEXUS can support expectations for future cash flows, while...
NYSE:XYZ
NYSE:XYZDiversified Financial

Tariff Refund Cash Is Lifting These US Financial Stocks Onto Investor Radar

US$166b in tariff refunds plus interest is quietly reshaping corporate cash piles, at the same time that fresh trade barriers and a wider US fiscal deficit keep markets on edge. That mix of extra liquidity and higher risk is creating potential winners among financial stocks that sit closest to new corporate cash. This article unpacks the tariff story and highlights three stocks exposed to these refunds that investors may want to keep on their radar. The sample stocks covered below are just a...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Pharmaceuticals (CRNX) Stock Looks Overvalued Despite Strong 3 Year Returns

Crinetics Pharmaceuticals has delivered a very strong share price run over the past three years, yet its current valuation screens as expensive on market multiples and the broader checks only give it a mixed score. That combination leaves investors weighing a powerful recent return against signals that the stock is not clearly cheap at today’s price of US$84.75. Crinetics Pharmaceuticals has returned 428.0% over the past three years, which sets a high bar for any further gains to be...
NYSE:KRMN
NYSE:KRMNAerospace & Defense

Karman Holdings (KRMN) Could Be 42% Below Fair Value Following Earnings And Guidance

Karman Holdings earnings, guidance and financing moves in focus Karman Holdings (KRMN) is in focus after second quarter 2026 results, updated full year revenue guidance and a refinancing of its credit facilities that changes the cost of its existing debt structure. See our latest analysis for Karman Holdings. Karman Holdings' latest earnings, raised revenue guidance and credit agreement amendment come after a period where the share price has been volatile. The stock has a 1 month share price...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

NextDecade (NEXT) Stock Dropped, So What Is Driving Attention Now?

NextDecade (NEXT) has drawn investor attention after recent share price moves, with the stock closing at $6.95 on 18 August 2026. The company focuses on US liquefied natural gas export and carbon capture projects. See our latest analysis for NextDecade. Against that backdrop, NextDecade’s share price has pulled back in the short term, with a 30 day share price return down 9.51% and a 90 day share price return down 22.52%, while the year to date share price return of 29.18% contrasts with a 1...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Newmark Group (NMRK) CEO Transition Tests the Firm’s Expansion and Recurring-Revenue Strategy

Newmark Group, Inc. announced that long-serving CEO Barry Gosin, in the role since 1979, will step down on December 31, 2026, while remaining Chairman of Newmark & Company Real Estate, Inc. to support a smooth leadership transition. This leadership change comes as Newmark shows resilience in commercial real estate, with growing management services, leasing, and capital markets businesses despite broader sector challenges. Next, we’ll examine how Gosin’s planned CEO handover could influence...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox (RBLX) Launches Monster Battles As Fair Value Debate Splits Investors

Studio Mayflower’s launch of Monster Battles on Roblox (RBLX), featuring character work from Pokémon film director Tetsuo Yajima, gives investors fresh content to watch as the platform expands its global entertainment reach. See our latest analysis for Roblox. At a share price of $37.93, Roblox has seen short term momentum fade, with the 30 day share price return down 26.61% and the year to date share price return down 53.14%. However, the 3 year total shareholder return is up 40.69%. If you...